Cargando…

Oncogene-Induced Reprogramming in Acute Lymphoblastic Leukemia: Towards Targeted Therapy of Leukemia-Initiating Cells

SIMPLE SUMMARY: Acute lymphoblastic leukemia is a heterogeneous disease characterized by a diversity of genetic alterations, following a sophisticated and controversial organization. In this review, we present and discuss the concepts exploring the cellular, molecular and functional heterogeneity of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fregona, Vincent, Bayet, Manon, Gerby, Bastien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582707/ https://www.ncbi.nlm.nih.gov/pubmed/34771671 http://dx.doi.org/10.3390/cancers13215511

Ejemplares similares

Characterization and identification of leukemia initiating cells in pediatric acute lymphoblastic leukemia
por: Trentin, Luca, et al.
Publicado: (2014)

Modelling acute leukemias in mice: clonal evolution and the emergence of leukemic stem cells
por: Gerby, Bastien, et al.
Publicado: (2013)

Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse
por: Clappier, Emmanuelle, et al.
Publicado: (2011)

Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia
por: Tan, Shi Hao, et al.
Publicado: (2017)

Magnetic resonance imaging of the brain in survivors of childhood acute lymphoblastic leukemia
por: BADR, MOHAMED AHMED, et al.
Publicado: (2013)

Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?
por: Zhang, Ziting, et al.
Publicado: (2022)

Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in acute lymphoblastic leukemia
por: Herranz, Daniel, et al.
Publicado: (2015)

MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia
por: Astolfi, Annalisa, et al.
Publicado: (2013)

Targeting chemokines for acute lymphoblastic leukemia therapy
por: Hong, Zixi, et al.
Publicado: (2021)

YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia
por: Li, Huan, et al.
Publicado: (2023)

Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia
por: Jin, Qi, et al.
Publicado: (2022)

Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment
por: Dyczynski, Matheus, et al.
Publicado: (2018)

Towards personalized chemotherapy of acute lymphoblastic leukemia
por: Hnízda, Aleš, et al.
Publicado: (2018)

Monoallelic Heb/Tcf12 Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia
por: Veiga, Diogo F. T., et al.
Publicado: (2022)

Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia
por: Kourtis, Nikos, et al.
Publicado: (2018)

Molecular Detection of Fusion Oncogenes in Zambian Patients with Acute Lymphoblastic Leukemia
por: Okuku, Pauline, et al.
Publicado: (2020)

WDR54 exerts oncogenic roles in T‐cell acute lymphoblastic leukemia
por: Li, Huan, et al.
Publicado: (2023)

A Metabolic Reprogramming Amino Acid Polymer as an Immunosurveillance Activator and Leukemia Targeting Drug Carrier for T‐Cell Acute Lymphoblastic Leukemia
por: Li, Changzheng, et al.
Publicado: (2022)

NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia
por: Kusy, Sophie, et al.
Publicado: (2010)

Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia
por: Xu, Huan, et al.
Publicado: (2021)

Acute renal failure as an initial manifestation of acute lymphoblastic leukemia
por: Bhatia, N. G., et al.
Publicado: (2013)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

Toward the Cure of Acute Lymphoblastic Leukemia in Children in China
por: Chen, Si-Liang, et al.
Publicado: (2021)

Oncogenic lesions and molecular subtypes in adults with B‐cell acute lymphoblastic leukemia
por: Yasuda, Takahiko, et al.
Publicado: (2022)

Targeting mTOR in Acute Lymphoblastic Leukemia
por: Simioni, Carolina, et al.
Publicado: (2019)

Targeting Telomere Biology in Acute Lymphoblastic Leukemia
por: Karow, Axel, et al.
Publicado: (2021)

Targeting Metabolic Reprogramming in Acute Myeloid Leukemia
por: Castro, Isabel, et al.
Publicado: (2019)

Advancements in Therapy for Acute Lymphoblastic Leukemia: Blinatumomab
por: Hladnik,1, Lindsay, et al.
Publicado: (2016)

Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia
por: Mezzatesta, Caterina, et al.
Publicado: (2019)

Reprogramming of Notch1-induced acute lymphoblastic leukemia cells into pluripotent stem cells in mice
por: Zhang, H, et al.
Publicado: (2016)

Low backache in adults as an initial presentation of acute lymphoblastic leukemia
por: Garg, Gunjan, et al.
Publicado: (2017)

RUNX1 colludes with NOTCH1 to reprogram chromatin in T cell acute lymphoblastic leukemia
por: Islam, Rashedul, et al.
Publicado: (2023)

Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
por: Ghelli Luserna Di Rorà, Andrea, et al.
Publicado: (2018)

Pediatric Acute Lymphoblastic Leukemia Emerging Therapies—From Pathway to Target
por: Ivanov, Anca Viorica, et al.
Publicado: (2023)

Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms
por: Lejman, Monika, et al.
Publicado: (2021)

The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia
por: Murgo, Emanuele, et al.
Publicado: (2023)

N-Me, a long range oncogenic enhancer in T-cell acute lymphoblastic leukemia
por: Herranz, Daniel, et al.
Publicado: (2014)

JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia
por: Mansour, Marc R., et al.
Publicado: (2018)

Long noncoding RNA PVT1: potential oncogene in the development of acute lymphoblastic leukemia
por: YAZDI, Narjes, et al.
Publicado: (2018)

Aberrant Activation of the GIMAP Enhancer by Oncogenic Transcription Factors in T-cell Acute Lymphoblastic Leukemia
por: Liau, Wei-Siang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gu9bben2eu8vkj9onlmfcj6n11